Related Experiment Video
Updated: Dec 30, 2025
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.8K
Multimorbidity among elderly in Bangladesh
Hasna Hena Sara1, Muhammad Abdul Baker Chowdhury2, Md Aminul Haque1
1Department of Population Sciences University of Dhaka Dhaka Bangladesh.
Aging Medicine (Milton (N.S.W))
|January 17, 2020
Summary
Over half of hospitalized elderly individuals in Bangladesh experience multimorbidity, with higher rates in women. This highlights an urgent need for specialized geriatric care services and targeted interventions to manage multiple chronic diseases.
Area of Science:
- Gerontology
- Public Health
- Epidemiology
Background:
- Multimorbidity, defined as having at least two chronic diseases, is a growing concern in aging populations, particularly in developing nations like Bangladesh.
- The prevalence of multimorbidity among the elderly in Bangladesh remains understudied, despite the increasing elderly population.
Purpose of the Study:
- To determine the prevalence of multimorbidity in hospitalized elderly individuals in Bangladesh.
- To identify common co-occurring chronic conditions in this demographic.
Main Methods:
- A cross-sectional study was conducted involving 566 adults aged 60 years and above admitted to two tertiary hospitals.
- Data collection involved in-person interviews using a semi-structured schedule and review of medical examination reports.
- Descriptive statistics were employed to analyze the prevalence of multimorbidity.
Main Results:
- The overall prevalence of multimorbidity among hospitalized elderly was 56.4%.
- Females exhibited a higher prevalence (64.18%) compared to males (54.17%).
- The most frequently observed conditions included hypertension (33.0%), diabetes (27.6%), ischemic heart disease (12.0%), and chronic obstructive pulmonary disease (9%).
Conclusions:
- The high prevalence of multimorbidity underscores the critical need for enhanced geriatric healthcare services in Bangladesh.
- Policymakers must prioritize the development of effective intervention strategies and programs to alleviate the burden of multiple chronic diseases in the elderly population.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
180
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
180
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
150
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
150
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
161
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
161
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
180
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
180
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
196
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
196
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
150
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
150